A carregar...

Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study

BACKGROUND: Pneumococcal vaccine provides protection against invasive pneumococcal disease in population at risk. This study was conducted to compare the antibody response to 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in patients with thalassemia major...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Caspian J Intern Med
Main Authors: Rezai, Mohammad Sadegh, Ghaffari, Javad, Mahdavi, Mohammadreza, Bahari, Amir, Ala, Shahram
Formato: Artigo
Idioma:Inglês
Publicado em: Babol University of Medical Sciences 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412244/
https://ncbi.nlm.nih.gov/pubmed/28503278
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!